Verici Dx plc (LON:VRCI – Get Free Report)’s share price shot up 5.7% during mid-day trading on Thursday . The company traded as high as GBX 0.40 and last traded at GBX 0.37. 308,972 shares were traded during mid-day trading, a decline of 81% from the average daily volume of 1,586,309 shares. The stock had previously closed at GBX 0.35.
Verici Dx Stock Performance
The stock has a market cap of £11.05 million, a price-to-earnings ratio of -0.41 and a beta of 1.26. The company has a quick ratio of 8.49, a current ratio of 3.94 and a debt-to-equity ratio of 3.03. The company has a 50 day simple moving average of GBX 0.38 and a 200 day simple moving average of GBX 0.51.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Stories
- Five stocks we like better than Verici Dx
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
